Pretransplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: Initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies

Bone Marrow Transplantation for Adolescents and Young Adults with Sickle Cell Disease: Results of a Prospective Multicenter Pilot Study

(2019) Lakshmanan Krishnamurti et al.   AMERICAN JOURNAL OF HEMATOLOGY

Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial

(2018) Shalini Shenoy et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide

(2018) Haydar Frangoul et al.   BONE MARROW TRANSPLANTATION

Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative

(2018) Josu de la Fuente et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease

(2016) Shalini Shenoy et al.   BLOOD

Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors

(2016) U Anurathapan et al.   BONE MARROW TRANSPLANTATION

Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

(2014) Sung-Yun Pai et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mixed chimerism and graft loss in pediatric recipients of an alemtuzumab-based reduced-intensity conditioning regimen for non-malignant disease

(2014) Benjamin R. Oshrine et al.   PEDIATRIC BLOOD & CANCER

Pretransplant Immunosuppression followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control

(2013) Usanarat Anurathapan et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major

(2013) Ayad Ahmed Hussein et al.   PEDIATRIC BLOOD & CANCER

Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia

(2013) G. Lucarelli et al.   Cold Spring Harbor Perspectives in Medicine

Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

(2012) Naynesh R. Kamani et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Treosulfan-Thiotepa-Fludarabine–Based Conditioning Regimen for Allogeneic Transplantation in Patients with Thalassemia Major: A Single-Center Experience from North India

(2012) Dharma Choudhary et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan

(2012) M. E. Bernardo et al.   BLOOD

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease

(2012) J. Bolanos-Meade et al.   BLOOD

Hematopoietic stem cell transplantation for thalassemia

(2012) Yasser Elborai et al.   Immunotherapy

Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease

(2009) Matthew M. Hsieh et al.   NEW ENGLAND JOURNAL OF MEDICINE

The National Marrow Donor Program 20 Years of Unrelated Donor Hematopoietic Cell Transplantation

(2008) Karen K. Ballen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Advances in the allogeneic transplantation for thalassemia

(2007) Guido Lucarelli et al.   BLOOD REVIEWS